Abstract:Abstract Introduction Untargeted metabolomics, an analysis of the molecular layer comprising many smaller molecular weight biomolecules, has emerged as a tool to diagnose and predict outcomes early in disease courses. Existing studies of metabolic changes following burn injury focus on select targeted metabolites using animal models. This study aims to identify metabolic signatures associated with burn severity and clinical outcomes using untargeted metabolomics analysis in patients. Methods Burn patients admitted to a regional center over the span of 4 years were prospectively enrolled in this study. Patient demographics, burn injury characteristics, and blood samples were collected at set timepoints from admission until 4 weeks. Mass spectrometry (MS)-based method was used to measure untargeted metabolomics. Comparison of the MS-based measurements of select metabolites with alternate standard clinical assaying was performed to ensure concordance and reliability. A linear regression model was then used to identify metabolites associated with bun severity (TBSA < 20% and ≥ 20%). Age, gender, BMI, presence of inhalation injury, administration of propofol and supplemental nutrition were added as covariates to control for confounding effects. Results Complete metabolome datasets were collected for 58 patients from a total of 115 patients reviewed. The sample had a median TBSA of 18.3%, median age of 38.5 and 27.6% had concomitant inhalation injury. A total of 925 metabolites, including 335 lipids, 183 amino acids, 146 xenobiotics, 24 carbohydrates, and 23 peptides were analyzed. MS-based measurements compared with alternate standard clinical assaying resulted in a high level of concordance (R ~ 0.8). The first two principal components (account for 22% of total variance) show the main drivers of global metabolomics variation are time since admission and severity of injury. At admission, a significant elevation of xenobiotics, amino acids, nucleotide, and lipids related metabolites was observed among severely burned patients (TBSA ≥ 20%). Longitudinal analysis reveal that xenobiotic related metabolites are significantly elevated at admission but are depleted overtime. An abundance of select metabolites at admission showed an excellent ability to predict 30-day mortality (AUROC ~ 90%). Conclusions Patterns of metabolic alterations were associated with severe burn injury (TBSA ≥ 20%). Distinct classes of metabolic profiles change in a time dependent manner. Therefore, metabolic profiling has the potential to be used as early indicators of disease severity and progression. Applicability of Research to Practice Identifying and utilizing early indicators of disease severity and outcomes before the onset of clinical signs is crucial for burn patients. Metabolomic changes is a prime candidate for the development of these prognostic and biomarker panels.

Metabolic Dynamics in Critically Injured Patients: a Prospective Cohort Study Integrated with 1H NMR Metabolomics.

Systemic Metabolic Changes of Traumatic Critically Ill Patients Revealed by an NMR-based Metabonomic Approach.

1H-nuclear magnetic resonance analysis reveals dynamic changes in the metabolic profile of patients with severe burns

Use of 1 H-nuclear magnetic resonance to screen a set of biomarkers for monitoring metabolic disturbances in severe burn patients

Plasma metabolomic profiles predict near-term death among individuals with lower extremity peripheral arterial disease.

IDDF2024-ABS-0027 the Prognostic Value of Serum Metabolites in Predicting Hepatic Decompensation among Patients with Cirrhosis

Metabolomics on Vascular Events and Death after Acute Ischemic Stroke: A Prospective Matched Nested Case-Control Study

21 Untargeted Metabolomics Analysis: A Candidate Biomarker and Prognostic Tool in Burn Injury

A metabonomic approach to early prognostic evaluation of experimental sepsis by 1H NMR and pattern recognition

Establishment of Quantitative Severity Evaluation Model for Spinal Cord Injury by Metabolomic Fingerprinting

An Integrated Clinico-Metabolomic Model Improves Prediction of Death in Sepsis

The Use of Gas Chromatography Coupled with High-Resolution Mass Spectrometry-Based Untargeted Metabolomics to Discover Metabolic Changes and Help in the Determination of Complex Causes of Death: A Preliminary Study

A metabonomic approach to early prognostic evaluation of experimental sepsis.

Nuclear magnetic resonance-based serum metabolomic analysis reveals different disease evolution profiles between septic shock survivors and non-survivors

A metabonomic approach to the early prognostic evaluation of sepsis using HPLC/MS in rat model

Establishing ¹H Nuclear Magnetic Resonance Based Metabonomics Fingerprinting Profile for Spinal Cord Injury: a Pilot Study.

Blood-Derived Metabolic Signatures as Biomarkers of Injury Severity in Traumatic Brain Injury: A Pilot Study

Differential Network Analysis Reveals Metabolic Determinants Associated with Mortality in Acute Myocardial Infarction Patients and Suggests Potential Mechanisms Underlying Different Clinical Scores Used To Predict Death

Plasma Metabolic Profiling and Multiclass Diagnostic Model Development for Stable Angina Pectoris and Acute Myocardial Infarction

Optimization of Brain Metabolism Using Metabolic-Targeted Therapeutic Hypothermia Can Reduce Mortality from Traumatic Brain Injury

Metabolomics analysis of the hippocampus in a rat model of traumatic brain injury during the acute phase